• 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

ONCSM Share Price Performance

₺229.50
130.95 (132.88%)
₺229.50
130.95 (132.88%)
Price ₺229.50

ONCSM Community Narratives

There are no narratives available yet.

Snowflake Analysis

Adequate balance sheet with acceptable track record.

1 Risk
1 Reward

Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi Key Details

₺578.5m

Revenue

₺366.8m

Cost of Revenue

₺211.7m

Gross Profit

₺181.8m

Other Expenses

₺30.0m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
1.26
36.60%
5.18%
4.2%
View Full Analysis

About ONCSM

Founded
2008
Employees
346
CEO
Erol Celik
WebsiteView website
www.oncosem.com

Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi manufactures and sells chemotherapy drug preparation kits, medical devices, and test kits in Turkey. The company offers OncoCare Monolitik, an automated chemotherapy drug preparation device; OncoCare Plus, a chemotherapy drug guide; OncoWaste and M-Waste, a hazardous waste sealing system, chemotherapy drugs, cephalosporins, penicillins, infectious waste and toxic laboratory waste; OncoCare Set, a chemotherapy preparation and administration consumables; and Oncocare Infusion Pump. It also provides Oncosem components, such as pinch clamps, roller clamps, 3/4 way connectors, vial adapters, drip chambers, hydrophobic caps, male and rotating luer locks, spikes, taxol filters, check valves, and covers. The company was incorporated in 2008 and is headquartered in Ankara, Turkey.

Recent ONCSM News & Updates

Recent updates

No updates